Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMRN | BMY | AMGN | GILD | VRTX |
| Company | Biomarin Pharmaceuticals | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 90.03 | 49.16 | 272.14 | 67.09 | 404.00 |
| High | 92.21 | 49.47 | 274.48 | 67.68 | 406.86 |
| Low | 89.93 | 48.96 | 271.05 | 67.00 | 403.47 |
| Last | 92.06 | 48.99 | 273.54 | 67.03 | 404.91 |
| Change | +2.57 | -0.15 | +1.63 | +0.08 | +4.99 |
| % Change | +2.87% | -0.31% | +0.60% | +0.12% | +1.25% |
| Volume | 1,299,000 | 9,153,200 | 2,493,300 | 5,240,200 | 1,070,300 |
| 20-Day Average Volume | 1,393,165 | 10,953,850 | 2,216,505 | 6,335,325 | 977,305 |
| Previous Close | 89.49 | 49.14 | 271.91 | 66.95 | 399.92 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 89.07 | 50.55 | 271.99 | 69.34 | 404.17 |
| 20-Day Raw Stochastic | 83.20% | 20.04% | 46.12% | 14.18% | 45.66% |
| 20-Day Relative Strength | 59.96% | 41.71% | 48.69% | 32.82% | 47.90% |
| Weighted Alpha | -0.88 | -25.74 | +11.45 | -20.86 | +17.74 |
| Today's Opinion | 32% Buy | 88% Sell | 40% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 8% Buy | 88% Sell | 40% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 88% Sell | 24% Sell | 8% Buy | 88% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.31% since 04/16/24 | +1.51% since 04/16/24 | +2.97% since 04/16/24 | -0.42% since 04/16/24 | +2.72% since 04/16/24 |
| Low | 88.29 on 04/19/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 92.21 on 04/23/24 | 49.56 on 04/22/24 | 274.48 on 04/23/24 | 67.68 on 04/23/24 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | +8.14% since 03/22/24 | -5.66% since 03/22/24 | -0.95% since 03/22/24 | -7.68% since 03/22/24 | -2.59% since 03/22/24 |
| Low | 84.70 on 03/25/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 93.36 on 04/15/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -1.05% since 01/23/24 | -2.25% since 01/23/24 | -11.74% since 01/23/24 | -15.66% since 01/23/24 | -7.91% since 01/23/24 |
| Low | 83.44 on 03/15/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 94.15 on 02/23/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +11.13% since 10/23/23 | -12.52% since 10/23/23 | +0.18% since 10/23/23 | -13.58% since 10/23/23 | +10.13% since 10/23/23 |
| Low | 76.02 on 11/02/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 341.90 on 11/16/23 |
| High | 99.56 on 12/14/23 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 16,889,804 | 99,594,944 | 145,845,984 | 83,357,904 | 103,362,928 |
| Shares Outstanding, K | 188,734 | 2,026,759 | 536,376 | 1,245,077 | 258,459 |
| Annual Sales | 2,419,230,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | 167,650,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 646,210,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | 20,380,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 0.31 | 0.39 | 0.58 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.49 on 02/22/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 04/24/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 70.90 | 6.52 | 14.42 | 9.93 | 29.34 |